AngioDynamics receives 510(k) clearance for AlphaVac mechanical thrombectomy system

407

AngioDynamics recently announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the AlphaVac mechanical thrombectomy system.

According to a company press release, AlphaVac is an off-circuit, multipurpose mechanical aspiration thrombectomy device for the non-surgical removal of thrombi or emboli from the vasculature.

AngioDynamics continues to anticipate the commercial release of the AlphaVac system in the second half of calendar year 2021.


LEAVE A REPLY

Please enter your comment!
Please enter your name here